Extra copies of EGFR gene signal poor prognosis for vulvar cancer

October 01, 2008

Targeted treatment of gene-amplified tumors may improve outcomes

A genetic fingerprint identified in patients with a gynecologic cancer may reveal candidates for targeted therapy. In a study in the journal Gynecologic Oncology, investigators from the Massachusetts General Hospital (MGH) Obstetrics and Gynecology Service report that women with vulvar carcinoma whose tumors have extra copies of the epidermal growth factor receptor (EGFR) gene are at increased risk of dying from their cancer. The EGFR pathway is known to be critical in several types of cancer, but this is the first association of an EGFR gene alteration with this tumor.

"Treatment for vulvar carcinoma has changed little over the years." says Bo Rueda, PhD, of the Vincent Center for Reproductive Biology in the MGH Obstetrics and Gynecology Service, co-senior author of the report. "Through a better understanding of the specific mechanisms that underlie the tumorigenic process, we hope to expand treatment options for these patients with molecularly targeted therapies." The study was a collaboration with MGH Cancer Center investigators.

Although cancer of the vulva -- women's exernal genital structures -- is rare, it frequently recurs after standard treatment, and little has been known about factors leading to its development. Changes in the expression or activity of EGFR have been associated with many solid tumors, and patients whose cancers have EGFR mutations often can be successfully treated with drugs targeting the molecular pathway controlled by that receptor. The current study, which has been released online, was designed to investigate whether EGFR activity is also altered in vulvar tumors.

Using samples from the hospital's Tumor and Pathology Banks, the team analyzed data from 51 patients treated for vulvar carcinoma at the MGH Cancer Center from 1994 to 2007. Tumor samples were first evaluated for presence of the EGFR molecule, which revealed that the highest levels were found in more advanced tumors from patients with poorer survival.

Chromosomal analysis of the tumors showed that additional copies of the EGFR gene in tumor cells -- seen in 6 of the 51 samples analyzed -- likely contributed to overproduction of the protein in those patients. No mutations in the EGFR gene itself were seen; and although infection with the human papilloma virus (HPV) is a known risk factor for vulvar cancer, there was no evidence of HPV infection in the EGFR-amplified tumors. Overall, patients with EGFR-amplified tumors were twice as likely to die from their cancer as were those without gene amplification.

"The increased risk of death associated with EGFR amplification was independent of other known factors -- such as age, stage of disease and spread to lymph nodes," says Whitfield Growdon, MD, the study's lead author and an MGH Gynecologic Oncology fellow. "EGFR amplification is now being used to identify patients eligible for clinical trials of novel EGFR-targeted therapies for several types of tumors."

Daniel Haber, MD, PhD, director of the MGH Cancer Center, adds, "This analysis shows that high levels of EGFR amplification are present in a variety of different cancers that have not been analyzed to date, raising the possibility of more therapeutic opportunities for the emerging array of EGFR-directed agents"

Massachusetts General Hospital

Gynecologic Oncology: Clinical Practice and Surgical Atlas
by Beth Karlan (Author), Robert Bristow (Author), Andrew Li (Author)

Introducing the definitive gynecologic oncology reference and surgical atlas—in one essential text Gynecologic Oncology: Clinical Practice and Surgical Atlas brings together a skill-sharpening reference and full-color atlas to deliver an unmatched introduction to the field. As the most comprehensive, evidence-based gynecologic oncology resource available, this all-in-one resource offers high-yield coverage of the discipline’s underlying principles and proven management strategies. Each topic is written by experts and is presented in an easily accessible, consistent presentation that highlights clinical practice guidelines, along with the diagnosis and treatment of specific malignancies. This authoritative coverage is reinforced by the state-of-the-art surgical atlas, which offers a...

Cancer Schmancer
by Fran Drescher (Author)

Part inspirational cancer-survival story, part memoir-as-a-laughriot, picks up where Fran's last book left off.

Clinical Gynecologic Oncology, 7e (Clinical Gynecologic Cncology)
by Philip J. DiSaia MD (Author), William T. Creasman MD (Author)

Thanks to improved detection technologies, early diagnosis and treatment, and innovative research, the outlook for gynecologic oncology patients is steadily improving every day. Offer your patients the best in diagnosis and management with the help of this leading reference on gynecologic malignancies. In addition to cancers of the female reproductive tract, the 7th Edition of this essential resource also discusses breast and colorectal disease, equipping you with the skills you need to provide effective and compassionate care for every patient.Recognize the clinical presentation of gynecologic malignancies with the aid of detailed chapters organized by cancer type and size. Apply authoritative guidance on all aspects of gynecologic oncology with appendices covering staging, screening,...

Clinical Gynecologic Oncology: Expert Consult - Online and Print, 8e (Clinical Gynecologic Oncology (Disaia))
by Philip J. DiSaia MD (Author), William T. Creasman MD (Author)

Clinical Gynecologic Oncology, by Drs. Di Saia and Creasman, is the leading medical reference book geared toward helping you improve gynecologic cancer outcomes. You'll see how to take advantage of the latest advances in early detection and improved treatment options for gynecologic cancers, especially uterine and cervical cancers, equipping you with the skills you need to provide effective and compassionate care for your patients.Easily identify and absorb key information with outlines beginning each chapter. Choose the best management plan for each patient using algorithms throughout the book. Stay at the forefront of your field thanks to new chapters on Genetic Counseling and Clinical Management of Inherited Disease; Molecular Genetics; and Minimally Invasive Surgery, plus sweeping...

OVARIAN CANCER: Current outlook on this deadly disease (Postgraduate Medicine)
by JTE Multimedia

The number of women in the United States dying of ovarian cancer continues to rise, primarily because in most patients, the disease is already so advanced at diagnosis that there is little chance of cure. What can be done for patients at the various stages of this disease? Dr Nahhas provides a comprehensive look at the current status of screening, prevention, and management of epithelial forms of ovarian cancer.

Original Publication Date: September 1997

100 Questions & Answers Abourt Cervical Cancer (100 Questions & Answers about . . .)
by Don S. Dizon (Author), Michael L. Krychman (Author), Paul DiSilvestro (Author)

The only text to provide both the patient and doctor views, 100 Questions & Answers About Cervical Cancer aims to provide a much needed primer for patients and their families and aims to address the questions most relevant to a woman following a diagnosis of pre-invasive changes or invasive cervical cancer. This text gives up-to-date, authoritative, practical answers to your questions about cervical cancer; not only the diagnosis and treatment of the disease, but also female survivorship. This is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease.

Dx/Rx: Gynecologic Cancer (Jones and Bartlett Publishers Dx/Rx Oncology Series)
by Don S. Dizon (Author), Susana M Campos (Author)

Written by two expert oncologists, specializing in female cancers, Dx/Rx: Gynecologic Cancer is a perfect pocket reference for all professionals involved in the care of women with gynecologic cancer. This handy, 136-page book provides comprehensive, up-to-date information on the epidemiology, symptoms, diagnosis, and management of malignancies of the ovaries, cervix, uterus, and fallopian tubes. Topics include a review of gynecologic tumors, detailed analysis on treatment strategies, and a discussion of past and current literature that has shaped the field. Presented in a concise, quick-reference format, Dx/Rx: Gynecologic Cancer is an essential guide for the care of women with malignancies of the reproductive system.

Gynecologic Oncology: Evidence-Based Perioperative and Supportive Care
by Steven A. Vasilev (Author), Scott E. Lentz (Author), Allison E. Axtell (Author)

New edition fully includes Grades and Levels of evidence, providing a better idea of what the sum total of existing evidence suggests regarding key topicsGrades and levels of evidence consistently highlighted throughoutGreater number of tables and algorithms ("decision trees") for key decision-making areas"Scope of concept" introduction to chapters are significantly enhanced, allowing the reader to reference the concepts while reviewing the specific details in the clinically oriented chaptersThe only available book with an evidence-based approach covering this specific subject matter in one compendium

Gynecologic Cancer (M.D. Anderson Cancer Care Series)
by Patricia J. Eifel (Editor), David M. Gershenson (Editor), John J. Kavanagh (Editor), Elvio G. Silva (Editor)

Gynecologic cancer includes cancer of the female lower genital tract: vagina, vulva, cervix, endometrium, uterus, and ovaries. Gynecologic Cancer is the fourth volume in the M.D. Anderson Cancer Care Series, featuring the current standard approach to gynecologic cancer care from the experts at M.D. Anderson Cancer Center. Designed for the practicing oncologist, this clinical guidebook allows for quick, authoritative access to the latest and best multimodality therapies. Topics covered in this volume include primary prevention and early detection, preinvasive diseases of female lower genital tract, pathology and imaging of gynecologica malignancies, treatment of vaginal, cervical, endometrial, uterine cancers. Discussions also address fertility-sparing options for treatment of women with...

Gynecologic Cancers (Site-Specific Cancer Series)
by L. Almadrones-cassidy (Author), L. Almadrones-cassidy (Editor)

Nurses who care for women diagnosed with gynecologic cancers are faced with a complex and unique set of challenges. Knowledge is needed not only in the management of a single cancer but in the many cancers that may affect the reproductive tract. This volume gives oncology nurses the tools they need to provide effective care to this challenging patient population. Gynecologic Cancers provides an overview of the current evidence-based information on the major tract of gynecologic cancers, causes, screening and preventive strategies, as well as the current surgical, chemotherapy, and radiation treatments used to treat all stages of the cancers. If you are involved in the complex treatment of women diagnosed with gynecologic cancers, you'll want to add this book to your nursing library!